Objective: Electroconvulsive therapy (ECT) is one of the most effective treatments for severe major depressive disorder. However, after acute-phase treatment and initial remission, relapse rates are significant. Strategies to prolong remission include continuation phase ECT, pharmacotherapy, psychotherapy, or their combinations. This systematic review synthesizes extant data regarding the combined use of psychotherapy with ECT for the treatment of patients with severe major depressive disorder and offers the hypothesis that augmenting ECT with depression-specific psychotherapy represents a promising strategy for future investigation.
lectroconvulsive therapy (ECT) is one of the most effective treatments for severe major depressive disorder (MDD) carrying benefits of relatively high response and initial remission rates a in an efficient time frame (eg, approximately 3Y4 weeks) compared with other antidepressant treatments (eg, 6 or more weeks). 1Y5 Despite the high efficacy of ECT, prolonged remission is uncertain and threatened particularly by lack of continued care. 6, 7 To protect against relapse after an acute-phase ECT, 2 primary strategies have been recommended: augmenting ECT with pharmacotherapy during the acute phase, 8, 9 or continuing the treatment course beyond early response with only one of these treatments. 10 A new untested strategy entails combining antidepressant medication with ECT throughout the acute and continuation phases of treatment, with continuation ECT administration based on individual symptom severity. 11 Yet, relative to the augmentation strategies common to pharmacotherapy, augmenting ECT with depression-specific psychotherapy has received limited attention. 12 There are 2 scientific rationales that support augmenting ECT with evidence-based psychotherapy. First, 2 contemporary psychotherapies, cognitive behavioral therapy (CBT) 13 and interpersonal psychotherapy (IPT) 14, 15 (often referred to as depression-specific psychotherapy) have been found efficacious in both the acute and continuation phases of treatment for MDD and have been shown to prolong remission and perhaps recovery. 16Y27 In addition, there is a substantial body of research highlighting improved clinical and functional outcomes when evidenced-based psychotherapy is combined with pharmacotherapy in the long-term treatment and management of patients with chronic treatment-resistant depression. 28Y30 Second, neuroimaging suggests that ECT and depressionspecific psychotherapy have distinct mechanisms of action that may result in specific treatment effects. Electroconvulsive therapy may decrease cerebral metabolic rate (rCMR) for glucose bilaterally in the superior frontal lobe (dorsolateral prefrontal cortex and medial prefrontal cortex), the parietal regions, posterior cingulate gyrus, and the medial temporal lobes. 31 On the other hand, studies suggest that there are early prefrontal changes with psychotherapy and differential responses throughout the course of therapy. 32Y35 For example, both the hippocampus and the mid-cingulate exhibit increased activity after psychotherapy whereas the orbital frontal and medial frontal cortices exhibit decreased activity. 32 Such changes in the mood regulating areas of the brain potentiate thinking and behavior changes associated with psychotherapeutic techniques. It has been hypothesized that ECT may work from the bottom up, whereas psychotherapy may work from the top down. 32,34 a The authors are using the conceptualization of response, remission, and recovery as defined by the American College of Neuropsychopharmacology Task Force (2006) . Original articles included in this review use synonymous terms although with different meaning, as they were published before publication of the ACNP Task Force. We present the terms as used in the original studies and, when appropriate, note the definition by either the ACNP Task force or the original study authors.
Considering the differential activation of these distinct brain regions, it seems reasonable to investigate the efficacy of augmenting ECT with depression-specific psychotherapy to improve the symptoms and functioning of patients with severe MDD. 36 Although the literature reflects a significant amount of research concerning the augmentation of antidepressant medication with psychotherapy, it has been assumed by some that posttreatment cognitive impairment impeded the effectiveness of individual psychotherapy. 37 Documented adverse effects of ECT include memory deficits, specifically anterograde amnesia (up to 1 month) for newly learned information, and retrograde amnesia (up to 6 months or longer) for autobiographical information. 38 These memory deficits seem to preclude psychotherapy, particularly if administered without awareness of the special needs of this population. However, given the advances in ECT and evidence-based psychotherapy, we hypothesize that with proper adaptation, depression-specific psychotherapy can be personalized as an augmentation intervention to meet the needs of severely depressed patients treated with ECT. The purposes of this paper were to provide a framework and rationale for this hypothesis, conduct a systematic review of available studies investigating previous combinations in the acute and continuation phase of treatment for MDD, and suggest starting points for developing this augmented or sequenced intervention for adults with severe depression.
SYSTEMATIC REVIEW METHOD
To accomplish the systematic literature review, 39 we (S.M.M. and A.R.B.) performed independent searches in the PsychInfo (1806Y2009) and Medline (1948Y2009) databases with the following terms: Electroconvulsive Therapy (including ECT, ECT therapy, electroshock therapy, EST, and shock therapy) and Psychotherapy (including cognitive behavioral, interpersonal, group, psychodynamic, psychoanalytic, individual, eclectic, and supportive). To control for duplicate information and redundancy, the results of the 2 independent searches were imported into and managed with EndNote (version X2 for Mac, The Thomson Corp, Carlsbad, Calif ). We included only those articles in this systematic review that mentioned ECT and psychotherapy (or one of the aforementioned variants) in the abstract and provided a case report, series, or clinical trial. A total of 6 studies (English language literature; Table 1 ) were included in this review. These studies were between the dates of 1946 and 2006, from the United States and the UK; the methodologies varied from theoretical conceptualizations and case reports to randomized controlled trials.
COMBINED USE OF ECT AND PSYCHOTHERAPY
The earliest publication describing the incorporation of psychotherapy with electroshock therapy (EST) b reported on 100 cases of psychoneuroses treated over a 5-year period at St James Hospital in Portsmouth, UK in 1946. 40 The authors suggested that psychiatric symptoms were caused by faulty electrical patterns in the brain, which, when altered by EST, resulted in an amnestic state that allowed for new simplified patterns to develop. Simple psychotherapy was given in the form of explanations and reassurance as the patient's memory returned, and occupational therapy was used to encourage the patient to take part in social activities. The course of treatment involved as many as 4 EST treatments a day, but no information is given about the frequency or even the use of formal psychotherapy sessions with patients. Patients were considered Brecovered[ when symptom-free and stable enough for discharge, and considered Brelieved[ when much improved but stability was in doubt. Within this nomenclature, 51% were classified as recovered, 46% as relieved, and 3% as Bnot improved.[ More than 10 years later, a group of American psychiatrists practicing at the Stony Lodge inpatient facility in New York published a preliminary report on 100 cases treated with regressive electroshock treatment or REST. 41 Although most of the patients were classified with some form of schizophrenia, manic depression was diagnosed in 2 of the patients. Considered a drastic treatment at the time (and today an unacceptable regimen by current psychiatric treatment standards), REST entailed multiple daily EST treatments continuing until the patient reached a state of infantile behavior characterized by amnesia, muteness, ataxia, and complete incontinence. At the termination of REST, the patient was then cared for as an infant, being slowly rehabilitated throughout the same developmental trajectory as a child (eg, being carried, fed by bottle, spoon-fed, taught to sit up and walk, toilet trained) by nursing assistants with specialized training. Psychotherapy in the protocol consisted of 2 or 3 short visits daily over 10 to 14 days during which the patient began emerging from the regressed state. Psychotherapeutic techniques included answering questions, acting as the patient's lost memory, and serving as a reassuring, stable person on whom a Bhelpless person[ may depend. Patient outcome was classified along a continuum anchored by Bunimproved[ (no change) and recovered (disappearance of symptoms, ability to function, and with adequate insight). Of the 2 patients being treated for manic depression, only one was classified as recovered with the other identified as improved.
Regressive electroshock treatment is also reported in the case study of a patient treated at the Menninger Clinic. 42 The treatment was described as a total of 30 electroshock treatments over a period of 10 consecutive days and, as memories returned, the patient was Bre-educated[ with psychotherapy 3 to 4 times a day by the treating psychiatrist. As the frequency of psychotherapy sessions was reduced, occupational therapy was introduced, and, upon discharge from the hospital, outpatient treatment was transferred to a supportive psychotherapist.
Jaffe et al 43 demonstrated the benefit of subconvulsive and convulsive electrostimulation (EST) as an adjunctive treatment to individual psychotherapy in a case report of an adult female patient with multiple psychiatric diagnoses (eg, depression, anxiety, and anorexia). Upon not showing benefit from a nonspecified psychotherapy alone, 2 courses of EST were adjunctively provided. The first course consisted of 12 subconvulsive treatments provided 3 times weekly, and the second course consisted of 14 convulsive treatments provided 3 times weekly. The patient was monitored by electroencephalography (EEG) during both EST courses. No change in EEG was observed with subconvulsive EST, but decreased slow wave activity was documented with convulsive EST. The authors suggested that the patient's clinical improvement was related to the physiological changes in the EEG, and that EST can benefit psychotherapy.
Group psychotherapy, another approach to the combination of psychotherapy and EST, is described in the multidisciplinary treatment of depression in a hospital inpatient unit. 44 Goals of the group were focused on the Breorganization and remolding of a patient's new growth[ after EST rather than on augmenting treatment for the disorders themselves. Patients were encouraged to process their feelings about the shock treatment and its concomitant adverse effects (eg, forgetfulness). The investigators reported favorable outcomes, including improvements in feelings of self-worth and self-awareness, reality-testing, and acquisition of positive coping mechanisms. The most recent investigations of psychotherapy and ECT tested the potential benefits of CBT. 37 Although methodological concerns dictate cautious interpretation (eg, n = 9, response established by a clinician's subjective report rather than by standardized instrument or masked independent evaluator, and lack of a control group), the authors concluded that CBT was of benefit to the study participants. Specifically, patients who received 12 weeks of CBT after an index course of ECT for MDD either maintained their response to ECT or continued to show decreased depressive symptoms at 6-and 9-month follow-ups as measured by the Beck Depression Inventory and the Clinical Global Impression Scale. Methodological concerns aside, these preliminary data in a small sample suggest a hypothesis worthy of attention: augmenting ECT with effective depression-specific psychotherapy (eg, CBT or IPT) will prove feasible and safe and will promote remission for patients with severe depression.
SUMMARY OF FINDINGS AND FUTURE DIRECTIONS
Prior research investigating the combined use of ECT and psychotherapy has reported beneficial effects in the treatment of psychiatric illness, but all studies varied in methodology, lacked appropriate controls, and provided limited data, making replication or strong conclusions difficult. Most authors did not provide information on psychotherapy, ECT procedures, or outcome measures (ie, type of stimulus waveform, electrode placement configuration, number of ECT treatments, type of psychotherapy, number of sessions, therapist qualifications, integrity of the psychotherapy, and symptom or severity rating scales). Most importantly, the majority of the historical studies reviewed did not adhere to robust controlled clinical science methods such as the inclusion of a comparative control group or control condition.
The established efficacy of depression-specific psychotherapy as monotherapy or augmentation in the treatment of chronic and/or severe MDD suggests that similar rigorous investigations of psychotherapy with ECT may fill an essential gap in clinical knowledge. Important covariates within the heterogeneous subtype of patients with MDD include patients with and without melancholic features, 45Y47 MDD with atypical features, 48, 49 MDD with psychotic features, 50Y53 recurrent MDD, 54Y56 and MDD with severe suicidal ideation.
57Y60
A major challenge to combining these 2 therapeutic modalities is the cognitive sequelae of ECT, which, if not taken into consideration, could potentially minimize the benefits of depression-specific psychotherapy. During the treatment course, disorientation (eg, forgetting the time of day and location) occurs and may last between 20 to 90 minutes after the ECT session. Anterograde amnesia has an onset during the first treatment and can persist for up to 1 month after the ECT course. Lastly, retrograde amnesia also has an onset during the first treatment and can persist for as long as 6 months after the ECT course. 38, 61 Although advances in ECT (Table 2 ) have minimized the cognitive adverse effects, these are still problematic for patients (for a full review of the cognitive effects of ECT, see Fraser et al 62 ). To mitigate the aforementioned challenge of temporarily impaired cognitive function, future investigations evaluating the efficacy and effectiveness of combination ECT and evidencedbased psychotherapy should ensure that both treatments are administered at optimum levels. Regarding ECT, parameters should be chosen that would result in the least adverse cognitive effects. Specifically, ECT should be administered with ultra-brief pulse waveform and dose titrated with the empirical titration method, electrode configuration should be right unilateral or bifrontal, and treatment should be systematically delivered until the patient achieves remission. 63 These parameters are essential to preserve cognitive functions. 64Y66 For example, psychotherapeutic treatment could be provided on days when ECT is not administered to allow the patient to regain, to the fullest extent possible, adequate cognitive function. At the same time, key questions to ask are: What is the critical time point at which to introduce evidence-based psychotherapy, and what are the key psychotherapeutic components to include in such a strategy? Such studies have been done in pharmacotherapy research, 67Y69 but a paucity of information remains within psychotherapy for the depression and ECT literature. Moreover, with established evidence of the beneficial combination of evidence-based psychotherapy and medication, 25 and ECT and medication, 9 another question emerges: Should pharmacotherapy be introduced with the combination of evidenced-based psychotherapy and ECT?
Beginning depression-specific psychotherapy before ECT and continuing it afterward deserves study. 70 Key components of the psychotherapeutic intervention might consist first of an introduction to the basics of the given depression-specific psychotherapy, and to MDD and ECT. Additional emphasis before ECT could be placed on teaching strategies for cognitive remediation the patient could use when learning new concepts (despite any impaired memory functions). These key components need to be interwoven and repeated to produce a depression-specific psychotherapy tailored to patients with severe depression who also have cognitive adverse effects secondary to ECT.
Just as CBT and IPT have been adapted according to the unique needs of specific populations, these standard structured approaches require modifications tailored to ECT patients. For example, in such tailoring, a heavy focus on behavioral activation could be helpful. 71 Cognitive behavioral interventions such 25 suggest that CBT and IPT are beneficial in patients with severe depression, may improve treatment response when combined with other antidepressant treatments (eg, pharmacotherapy), and can have lasting therapeutic effects. Thus, there is evidence to suggest that CBT and IPT can be useful augmentation strategies for patients with severe depression. A next step would be to adapt those strategies for patients undergoing ECT.
Standard neurocognitive instruments such as the Mini Mental State Examination 72 or the Montreal Cognitive Assessment 73 may be useful to document the global cognitive function status of the patient to better assess suitability for psychotherapy or determine necessary adaptations during the therapy process. Although no specific neurocognitive instrument for use with patients undergoing ECT exists at this time, global cognitive instruments can help establish that the patient is oriented and is able to attend to verbal and visual information.
In addition, prospective research may benefit from the American College of Neuropsychopharmacology (ACNP) Task Force 72 and others' recommended definitions for response, remission, recovery, relapse, and recurrence. 74, 75 Without consensus on these terms, confident interpretation of clinical outcomes is compromised. The ultimate goal of patient-oriented research is to effect change in community practice, provide clinicians and patients the knowledge necessary to inform treatment for MDD and make cost effective decisions, and most importantly, to promote complete recovery. 76 In conclusion, based on the advances in ECT and evidencebased psychotherapies, their combined use warrants reappraisal and further investigation in the treatment and management of patients with MDD. As newer, more effective antidepressant strategies are needed and developed to prevent relapse and recurrence, 77, 78 there is a vital interest in the development and evolution of multimodal therapies that are both individualized and targeted to the specific psychiatric disorders and targeted to unique patient groups. 79 Given the limited uncontrolled, yet encouraging prior findings, 80 future research is warranted to better integrate the beneficial attributes of ECT and evidencedbased psychotherapy. Thus, we hypothesize that the proposed combined or augmented uses may benefit patients and that this intervention strategy is worthy of rigorous testing using cuttingedge research methodologies.
